In contrast, research on the mouse lung cancer model appears, where it has been shown that overexpression of this protein is associated with poor forecasts in therapy, and HSPA5 inhibition by HA15 promoted the apoptosis of tumour cells (Wu et al., 2020). This evidence concerns the gene HSPA5 and lung carcinoma.